Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03285893 · ClinicalTrials.gov registry record
Oral Cell DNA Adducts in Smokers
A clinical trial, sponsored by University of Minnesota.
- Completed
- Registry status
- 281
- Enrollment target
NCT03285893 is a clinical trial that has completed, run by University of Minnesota. The registered enrollment target is 281 participants.
The verdict
NCT03285893 has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- 281 participants
- Enrollment target
Study Summary
DNA adducts in the oral mucosa cells of 100 smokers from 3 ethnic groups - Native Hawaiians, Whites, and Japanese Americans with differing risks for lung cancer upon cigarette smoking will be quantified. DNA adducts of tobacco smoke carcinogens will be quantified using both targeted and untargeted approaches.
Interventions
- OTHER oral cell DNA adducts
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 281 participants |
| Start Date | 2018-02-01 |
| Est. Completion | 2021-08-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03285893
The ClinicalTrials.gov registry entry for NCT03285893 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 281 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which oral cell DNA adducts is the first listed.
NCT03285893 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03285893 about?
NCT03285893 is a clinical study titled "Oral Cell DNA Adducts in Smokers". DNA adducts in the oral mucosa cells of 100 smokers from 3 ethnic groups - Native Hawaiians, Whites, and Japanese Americans with differing risks for lung cancer upon cigarette smoking will be quantified. DNA adducts of tobacco smoke carcinogens will be quantified using both targeted and untargeted a...
What is the current status of trial NCT03285893?
This trial is currently completed. The enrollment target is 281 participants. The study started on 2018-02-01. Estimated completion is 2021-08-01.
What interventions are being tested in trial NCT03285893?
The interventions under investigation include: oral cell DNA adducts (OTHER).
Who is sponsoring clinical trial NCT03285893?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.